Roflumilast, a Type 4 phosphodiesterase inhibitor, shows promising adjunctive, host-directed therapeutic activity in a mouse model of tuberculosis

by Maiga, M.C, Ahidjo, B.A, Maiga, M, Bishai, W.R
Published 2020

VapC toxins from Mycobacterium tuberculosis are ribonucleases that differentially inhibit growth and are neutralized by cognate vapB antitoxins

by Ahidjo B.A., Kuhnert D., McKenzie J.L., Machowski E.E., Gordhan B.G., Arcus V., Abrahams G.L., Mizrahi V.
Published 2020